(Q79899499)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

An application of meta-analysis techniques in the evaluation of adverse experiences with antihypertensive agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Sakai H

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Hayashi K

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Origasa H

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kusunoki T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

Pharmacoepidemiology and Drug Safety

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

169-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15073926%20AND%20SRC:MED&resulttype=core&format=json

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Long‐Term Survival and Use of Antihypertensive Medications in Older Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Tiapamil and hydrochlorothiazide: a double-blind comparison of two antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Nicardipine and hydrochlorothiazide in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Treatment of hypertension in the elderly with a new calcium channel blocking drug, nitrendipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Verapamil and bendrofluazide in the treatment of hypertension: a controlled study of effectiveness alone and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Comparison of nitrendipine and hydrochlorothiazide for systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Slowing of mitral valve annular calcium in systemic hypertension by nifedipine and comparisons with enalapril and atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Calcium entry blockade or beta-blockade in long-term management of hypertension in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: comparative double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Japanese and American reports of randomized trials: differences in the reporting of adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

What, if anything, is controversial about calcium antagonists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1557%28199905%2F06%298%3A3%3C169%3A%3AAID-PDS416%3E3.0.CO%3B2-F

10.1002/(SICI)1099-1557(199905/06)8:3<169::AID-PDS416>3.0.CO;2-F

21 January 2018

Identifiers

DOI

0 references

1 reference